Skip to main content
. 2013 Oct 18;23(2):455–462. doi: 10.1007/s00586-013-3072-2

Table 3.

TCV, TTV, ratio TTV to TCV, TDV, TNPV, TGPV at 20th and 40th weeks

Group/n 20th/40th week Control 4/4 TMX 4/4 RLX 4/4 p (ANOVA)
TCV (mm³) 20th/40th week 15.65 ± 0.89/15.53 ± 1.8 16.41 ± 3.38/14.57 ± 1.36 14.36 ± 3.63/11.43 ± 1.7 0.619/0.016
TTV (mm³) 20th/40th week 5.14 ± 0.53/5.13 ± 1.26 5.21 ± 0.98/6.79 ± 0.93 4.82 ± 1.5/4.68 ± 0.70 0.868/0.034
%TTV/TCV 20th/40th week 32.99 ± 4.59/31.53 ± 6.03 31.86 ± 1.81/47.09 ± 8.67 34.07 ± 7.27/41.31 ± 6.74 0.83/0.04
TDV (mm³) 20th/40th week 2.71 ± 0.27/2.96 ± 0.58 2.06 ± 0.74/2.62 ± 0.43 2.05 ± 0.35/1.99 ± 0.27 0.157/0.038
TNPV(mm³) 20th/40th week 0.54 ± 0.19/0.48 ± 0.28 0.32 ± 0.14/0.52 ± 0.16 0.30 ± 0.13/0.40 ± 0.85 0.114/0.703
TGPV (mm³) 20th/40th week 0.68 ± 0.06/0.59 ± 0.14 0.38 ± 0.12/0.48 ± 0.09 0.38 ± 0.13/0.46 ± 0.06 0.005/0.198

The p groups provided in the table are for ANOVA test of all groups and significant figures are presented in bold

TCV Total corpus volume, TTV Total trabecular volume, TDV Total disc volume, TNPV Total nucleus pulposus volume, TGPV Total growth plate volume